AU2003204277A1 - Treatment of hematologic disorders - Google Patents

Treatment of hematologic disorders

Info

Publication number
AU2003204277A1
AU2003204277A1 AU2003204277A AU2003204277A AU2003204277A1 AU 2003204277 A1 AU2003204277 A1 AU 2003204277A1 AU 2003204277 A AU2003204277 A AU 2003204277A AU 2003204277 A AU2003204277 A AU 2003204277A AU 2003204277 A1 AU2003204277 A1 AU 2003204277A1
Authority
AU
Australia
Prior art keywords
treatment
hematologic disorders
hematologic
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003204277A
Other versions
AU2003204277B2 (en
Inventor
Thomas R. Spitzer
Megan Sykes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU15857/99A external-priority patent/AU1585799A/en
Application filed by General Hospital Corp filed Critical General Hospital Corp
Priority to AU2003204277A priority Critical patent/AU2003204277B2/en
Priority claimed from AU2003204277A external-priority patent/AU2003204277B2/en
Publication of AU2003204277A1 publication Critical patent/AU2003204277A1/en
Application granted granted Critical
Publication of AU2003204277B2 publication Critical patent/AU2003204277B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003204277A 1997-11-14 2003-05-20 Treatment of hematologic disorders Ceased AU2003204277B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003204277A AU2003204277B2 (en) 1997-11-14 2003-05-20 Treatment of hematologic disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60073230 1997-11-14
AU15857/99A AU1585799A (en) 1997-11-14 1998-11-13 Treatment of hematologic disorders
PCT/US1998/024209 WO1999025367A2 (en) 1997-11-14 1998-11-13 Treatment of hematologic disorders
AU2003204277A AU2003204277B2 (en) 1997-11-14 2003-05-20 Treatment of hematologic disorders

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU15857/99A Division AU1585799A (en) 1997-11-14 1998-11-13 Treatment of hematologic disorders

Publications (2)

Publication Number Publication Date
AU2003204277A1 true AU2003204277A1 (en) 2003-06-19
AU2003204277B2 AU2003204277B2 (en) 2006-03-16

Family

ID=39338322

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003204277A Ceased AU2003204277B2 (en) 1997-11-14 2003-05-20 Treatment of hematologic disorders

Country Status (1)

Country Link
AU (1) AU2003204277B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104093314A (en) 2011-12-22 2014-10-08 耶达研究及发展有限公司 A combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion

Similar Documents

Publication Publication Date Title
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
AU1520699A (en) Methods for treatment of disorders of cardiac contractility
EP1063990A4 (en) Therapy of estrogen-associated disorders
PL339425A1 (en) Treatment of behavioural disorders
AU8963698A (en) Prosthesis of the spinal column
AU2972497A (en) Treatment of oils
AU1189399A (en) Bathocuproine treatment of neurologic disease
AU2058697A (en) Treatment of sleep disorders
AU1697197A (en) Immunoconjugate for the treatment of aids
AU1926597A (en) Treatment of cocoa
IL131347A0 (en) Treatment of skin disorders
AU1282099A (en) Method for treatment of disorders of attention
AU2003204277A1 (en) Treatment of hematologic disorders
AU6171196A (en) Therapeutic uses of ta99
AU7545998A (en) Treatment of osteoporosis
AU2671895A (en) Bisquinolines for the treatment of malaria
AU8557598A (en) Treatment of fluids
AU4310397A (en) Treatment of waste
AUPO504297A0 (en) Treatment of neurological disorders
AU7521598A (en) Aralkoxy-morphinan derivatives for treatment of cns disorders
AUPM424794A0 (en) Treatment of anorectal disorders
AU1991199A (en) A preparation for the treatment of aphtae
AUPP076997A0 (en) Treatment of glaucoma
AU3163795A (en) Treatment of autoimmune diseases
AU7346298A (en) Treatment of allergic conditions